Ipsogen’s MapQuant™ Dx genomic profiling solution uses the technology developed by Affymetrix (Santa Clara, CA, USA), the world leader on the microarray market.

Ipsogen partners with DNAVision SA (Gosselies, Belgium), a molecular analysis specialized private laboratory with ISO 17025 accreditation. DNA Vision SA is the very first laboratory compliant with Ipsogen MapQuant Dx™ quality standard.

Clinical partnerships with top European institutions

Ipsogen has research collaboration agreements with the Universite Libre de Bruxelles (Institut Bordet, Belgium), the Institut Paoli-Calmettes (Marseilles, France) and the French Federation of Anti-Cancer Centers (FNCLCC).

The MapQuant Dx™ solution has been designed to rapidly develop and validate new genomic tests into commercial products.

Ipsogen is always open to new partnerships with dynamic actors to expand its cutting-edge product offer to patients.

Do not hesitate to contact us.

  
• Plan du site  
• Contact  
• Informations légales